RT Journal
A1 Cohen PA
T1 DMaa as a dietary supplement ingredient
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2012
FD July 9
VO 172
IS 13
SP 1038
OP 1039
DO 10.1001/archinternmed.2012.1677
UL http://dx.doi.org/10.1001/archinternmed.2012.1677
AB 
The pharmaceutical amphetamine derivative 1,3-dimethylamylamine (DMAA) was introduced in 1948 as a nasal inhaler for rhinitis by Eli Lilly & Co. By the 1970s, it had been withdrawn as an approved pharmaceutical. Surprisingly, DMAA is currently used as an ingredient in roughly 200 sports supplements, many sold in major franchises throughout the United States, with sales topping $100 million in 2010 alone (Table).1- 4